INCREASED EXPRESSION OF OPIOID-DELTA RECEPTORS BY DEOXY CONFORMATION HEME-PROTEINS IN NG108-15 CELLS

被引:3
|
作者
MAYFIELD, KP [1 ]
HORVATH, R [1 ]
LAI, J [1 ]
PORRECA, F [1 ]
机构
[1] UNIV ARIZONA,ARIZONA HLTH SCI CTR,DEPT PHARMACOL,TUCSON,AZ 85724
关键词
DELTA OPIOID RECEPTOR; NALTRINDOLE; HYPOXIA; HEME PROTEIN; COBALT; 4,6-DIOXOHEPTANOIC ACID; NG108-15; CELL;
D O I
10.1016/0006-8993(95)00089-9
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Adaptations to prolonged hypoxia include an increase in the expression of proteins that may facilitate survival. One mechanism by which hypoxia increases protein expression involves a change of heme proteins from oxygenated to deoxygenated conformations. In the present study, we tested the hypothesis that treatment of NG108-15 cells with metallic cations, which are known to induce a deoxygenated conformation of heme proteins, would increase delta opioid receptor (DOR) expression. Cells were treated with cobalt and nickel, which induce deoxygenated heme protein conformation, or zinc as a control for 48 h prior to quantifying DOR expression. Cobalt and nickel, but not zinc, significantly increased DOR expression. Heme synthesis inhibitors would block the synthesis of cobalt-substituted heme proteins which are locked in a deoxygenated conformation. The cobalt-induced increase in DOR expression was blocked by the heme synthesis inhibitor, 4,6-dioxoheptanoic acid. These experiments indicate that deoxygenated conformation heme proteins, which are thought to partially mimic hypoxia, increase DOR expression. The increase in DOR expression suggests that the DOR gene may be hypoxia-sensitive. Further, the increase in DOR expression suggests a potential adaptation strategy to hypoxia and may represent one of the first findings of physiological regulation of DOR expression.
引用
收藏
页码:358 / 362
页数:5
相关论文
共 50 条
  • [31] BUTYRATE MODULATES THE EXPRESSION OF OPIOID, ALPHA2-ADRENERGIC AND MUSCARINIC CHOLINERGIC RECEPTORS IN NCB-20 AND NG108-15 CELLS
    ZHU, ZX
    CHUANG, DM
    FEDERATION PROCEEDINGS, 1987, 46 (04) : 1464 - 1464
  • [32] Intracellular dynamics of σ-1 receptors (σ1 binding sites) in NG108-15 cells
    Hayashi, T
    Su, TP
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2003, 306 (02): : 726 - 733
  • [33] CHARACTERIZATION OF BRADYKININ RECEPTORS SOLUBILIZED FROM RAT UTERUS AND NG108-15 CELLS
    SNELL, PH
    PHILLIPS, E
    BURGESS, GM
    SNELL, CR
    WEBB, M
    BIOCHEMICAL PHARMACOLOGY, 1990, 39 (12) : 1921 - 1928
  • [34] ETHANOL AND NALOXONE DIFFERENTIALLY UP-REGULATE DELTA-OPIOID RECEPTOR GENE-EXPRESSION IN NEUROBLASTOMA HYBRID (NG108-15) CELLS
    JENAB, S
    INTURRISI, CE
    MOLECULAR BRAIN RESEARCH, 1994, 27 (01): : 95 - 102
  • [35] NOVEL OPIOID BINDING-SITES ASSOCIATED WITH NUCLEI OF NG108-15 NEUROHYBRID CELLS
    BELCHEVA, M
    BARG, J
    ROWINSKI, J
    CLARK, WG
    GLOECKNER, CA
    HO, A
    GAO, XM
    CHUANG, DM
    COSCIA, C
    JOURNAL OF NEUROSCIENCE, 1993, 13 (01): : 104 - 114
  • [36] Influence of extracellular matrix proteins on membrane potentials and excitability in NG108-15 cells
    Kowtha, VC
    Bryant, HJ
    Pancrazio, JJ
    Stenger, DA
    NEUROSCIENCE LETTERS, 1998, 246 (01) : 9 - 12
  • [37] OPIOID RECEPTORS ARE COUPLED TIGHTLY TO G-PROTEINS BUT LOOSELY TO ADENYLATE-CYCLASE IN NG108-15 CELL-MEMBRANES
    COSTA, T
    KLINZ, FJ
    VACHON, L
    HERZ, A
    MOLECULAR PHARMACOLOGY, 1988, 34 (06) : 744 - 754
  • [38] MOLECULAR-CLONING OF A NOVEL PROTEIN REGULATED BY OPIOID TREATMENT OF NG108-15 CELLS
    WICK, MJ
    ANN, DK
    LOH, HH
    MOLECULAR BRAIN RESEARCH, 1995, 32 (01): : 171 - 175
  • [39] NOVEL OPIOID BINDING-SITES ASSOCIATED WITH THE NUCLEI OF NG108-15 NEUROHYBRID CELLS
    COSCIA, CJ
    BELCHEVA, MM
    ROWINSKI, J
    BARG, J
    CLARK, WG
    GAO, XM
    CHUANG, DM
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1993, : 252 - 252
  • [40] Delta opioids activate tyrosine kinase Src but not Fyn in NG108-15 cells.
    Mangoura, D
    Hansen, T
    JOURNAL OF NEUROCHEMISTRY, 1998, 70 : S13 - S13